Alliance is a specialty pharmaceutical company based in the United Kingdom. The company has a strong track record of acquiring the rights to established niche brands and owns or shares the rights to over 60 pharmaceutical products. Revenues in the year ending December 2012 were £44.9 million
Alliance maintains strategic and controlling functions with a management team possessing large pharmaceutical company experience. More capital intensive functions are outsourced to maximise efficiency and profitability.
The core of Alliances’ activities has been in the United Kingdom with the majority of sales based in the UK. However, Alliance has a growing international business with a direct presence in France, Germany, the Republic of Ireland, as well as distributor partners in over 25 other territories and a joint-venture operation in China.
Alliance has acquired brands from leading healthcare companies such as Novartis, Procter and Gamble, Lilly, Pfizer, Reckitt Benckiser and AstraZeneca. Alliance is constantly considering a number of in-licensing opportunities. At this stage we will look at possibilities in all therapy areas.
If you are seeking a UK and Europe market entry partner, Alliance's sales, marketing and regulatory expertise can help you navigate the whole process from marketing authorisation submission to field force deployment. Alliance will expand infrastructure to fit the opportunity.
Alliance focuses primarily on prescription branded medicines (in the human medical sector), but also has an important consumer OTC business. We have a number of clear business strategies for growth:
Business Development Director
Clients in focus...